(Q43612166)

25 November 2017

title

Pharmacokinetics and metabolism of formestane in breast cancer patients (English)

1 reference

25 November 2017

1 reference

1

Lønning PE

1 reference

25 November 2017

Geisler J

2

1 reference

25 November 2017

Johannessen DC

3

1 reference

25 November 2017

Gschwind HP

4

1 reference

25 November 2017

Waldmeier F

5

1 reference

25 November 2017

Schneider W

6

1 reference

25 November 2017

Galli B

7

1 reference

25 November 2017

Winkler T

8

1 reference

25 November 2017

Blum W

9

1 reference

25 November 2017

Kriemler HP

10

1 reference

25 November 2017

Miller WR

11

1 reference

25 November 2017

Faigle JW

12

1 reference

25 November 2017

language of work or name

1 reference

1 April 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

25 November 2017

published in

1 reference

25 November 2017

volume

77

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

39-47

1 reference

The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Aromatase inhibition for breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Pharmacokinetics of 4-hydroxyandrostenedione in man after intramuscular injection of different formulations and the effect of this drug on plasma aromatizable androgens and 17β-estradiol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Comparison of the pharmacokinetics and pharmacodynamics of unformulated and formulated 4-hydroxyandrostenedione taken orally by healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Quantitative determination of 4-hydroxy-4-androstene-3,17-dione (4-OHA), a potent aromatase inhibitor, in human plasma, using isotope dilution mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

The importance of local synthesis of estrogen within the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Second generation aromatase inhibitor--4-hydroxyandrostenedione

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900029-2

7 January 2021

10.1016/S0960-0760(01)00029-2

Identifiers

DOI

1 reference

25 November 2017

1 reference